The NIHR Biomedical Research Centre for Mental Health and King’s College London (BRC-MH) have joined GeneGo’s MetaMiner CNS Partnership Program. The goal is to develop a central nervous system (CNS) pathway-analysis platform, which includes developing a series of disease pathway maps for schizophrenia, Alzheimer’s disease, and Huntington’s disease. The program will also leverage experimental data from the public domain and make it available for analysis.
